Skip to main content
OpenTrials
Completed

NCT Number: NCT02554617

Measurements of Exhaled Nitric Oxide in Healthy Subjects in Thailand

The purpose of this study is to determine fractional exhaled nitric oxide (FeNO) level in healthy subjects among Thai populations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

6 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Siriraj Hospital

Bangkok, 10700, Thailand

About this study

Fractional exhaled nitric oxide (FeNO) were produced from epithelial cells of inflammatory airways and eosinophils and this gas was discovered since 1991.

Fractional exhaled nitric oxide (FeNO) has direct association with severity of inflammation of bronchial trees and sputum eosinophils and use for additional investigation for diagnosis asthma or inflammatory airway diseases.

There are many factors from previous studies that associate with level of fractional exhaled nitric oxide (FeNO), one of that factors is race therefore we can't use level from another studies with different race for use as reference and there is no study about level of fractional exhaled nitric oxide in Thai population.

It is therefore desirable to examine level of fractional exhaled nitric oxide (FeNO) in healthy subjects among Thai population and will be the main objective of this research.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy subjects in community

Exclusion criteria

  • smoker or past history of smoking
  • asthma, allergic rhinitis, chronic respiratory disease or other chronic illness
  • history of wheezing within 12 months before enrollment
  • history of upper or lower respiratory tract infection within 6 weeks before enrollment
  • drink ethanol within 48 hours before enrollment
  • drink caffeine within day before enrollment
  • during pregnancy
  • chronic use of any drugs
  • participate other project within 30 days

Treatment and study plan

Primary outcomes

  1. fractional exhaled nitric oxide level

    Time frame: 10 minutes (average time ), on the day of enrollment

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Registry information

Acronym: FeNO_nor

Important dates

Study start
2010
Primary completion
2015
Study completion
2015
First posted
Sep 18, 2015
Registry last updated
May 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.